Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

96
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dupilumab for Eosinophilic Esophagitis in Adolescents and Adults: Real-World Outcomes Across Different Dosing Regimens from the EoE CONNECT Registry.

The American journal of gastroenterology·2026
Same author

Towards a medical ethics of suffering: ontological and practical foundations.

Medicine, health care, and philosophy·2026
Same author

Comparative Efficacy and Safety of Swallowed Topical Corticosteroids in Eosinophilic Esophagitis: A Network Meta-Analysis.

Journal of clinical medicine·2025
Same author

Suffering and the collapse of language: between the sayable and the impossible.

Medical humanities·2025
Same author

Hospital-Acquired Pressure Injuries: Application of Preventive and Reactive Measures in Real Practice.

Journal of advanced nursing·2025
Same author

The Association Between Helicobacter pylori Infection and Eosinophilic Esophagitis: Systematic Review and Meta-Analysis.

Helicobacter·2025

Related Experiment Video

Updated: Jun 3, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

661

Allostatic Load as a Short-Term Prognostic and Predictive Marker.

Ana M Gómez García1,2,3, Angel Jesús Arias Arias2, Francisco López Muñoz2,3

  • 1Internal Medicine Unit, Hospital Universitario HM Madrid, Madrid, Spain.

Stress and Health : Journal of the International Society for the Investigation of Stress
|January 10, 2025
PubMed
Summary

Allostatic load, a measure of the body's strain from stress, effectively predicts severe COVID-19 outcomes, including prolonged hospitalization and mortality. This easily obtainable marker offers early, cost-effective disease prognosis for patients.

Keywords:
allostatic loadbiological dysregulationbiomarkersstress responses

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

15.8K

Related Experiment Videos

Last Updated: Jun 3, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

661
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

15.8K

Area of Science:

  • Biomedical science
  • Clinical research
  • Physiology

Background:

  • Allostatic load quantifies cumulative physiological strain from chronic stress.
  • Elevated allostatic load is linked to adverse health outcomes and increased mortality.
  • It serves as a measure of the body's adaptive capacity to stressors.

Purpose of the Study:

  • To evaluate allostatic load as a prognostic tool in hospitalized COVID-19 patients.
  • To assess the correlation between allostatic load and disease severity, including hospitalization duration, ICU admission, and mortality.
  • To determine if allostatic load can predict patient outcomes beyond COVID-19.

Main Methods:

  • Analysis of clinical and laboratory parameters in hospitalized COVID-19 patients.
  • Calculation of allostatic load based on established biomarkers.
  • Statistical analysis to correlate allostatic load with clinical outcomes such as hospital stay length, ICU days, and mortality.

Main Results:

  • Allostatic load significantly predicted prolonged hospitalization and increased ICU days.
  • Elevated allostatic load was a strong predictor of mortality in COVID-19 patients.
  • The findings highlight allostatic load's efficacy in gauging biological dysregulation during COVID-19 progression.

Conclusions:

  • Allostatic load is a valuable, easily obtainable prognostic marker for hospitalized patients.
  • It provides an early, cost-effective indication of disease severity and potential outcomes.
  • This marker shows promise for predicting prognosis in various critical illnesses, not limited to COVID-19.